Myths vs. Facts
The Patent Eligibility Restoration Act (PERA) is a bold, bipartisan fix for America’s broken patent system.
- Outdated court rulings have blocked innovation in diagnostics, personalized medicine, software, and AI — while global competitors surge ahead.
- PERA restores clarity, levels the playing field, and ensures U.S. inventors can protect their breakthroughs.
Support PERA today and help secure America’s leadership in innovation.
A coalition of anti-patent groups claim that restoring clarity on patent eligibility would hurt small businesses and that stronger patent rights would dampen innovation in important sectors like artificial intelligence. In reality, PERA would help to support inventors and entrepreneurs, promoting innovation in the United States.
PERA restores patent protection for real medical and biotech innovations while keeping strict limits in place. It does not allow patents on genes, natural phenomena, or basic science — but it ensures new tests, treatments, and life-saving technologies can be protected in the United States.
PERA reestablishes patent eligibility for true software, AI, and tech inventions, giving U.S. innovators the same protections as their global rivals. It does not allow patents on abstract ideas, mental steps, or math formulas — but it provides the certainty developers and startups need to invest, grow, and compete.